Drug Pipeline

Seladelpar Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
2
Phase 3
2
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-27 NCT06051617
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis		 Trial sites expanded: 196 -> 199 locations
Active Studies by Phase
Phase 3
2
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06051617 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis Primary Biliary Cholangitis Recruiting
NCT03301506 Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC) Primary Biliary Cirrhosis Active, Not Recruiting
Phase 2
NCT07305363 Seladelpar in Adult Liver Transplant Recipients With Ischemic Cholangiopathy (SELIC). Liver Transplant; Complications Not Yet Recruiting
Sponsors Running Seladelpar Trials
Gilead Sciences (2) University of California, San Diego (1)
Get alerts when Seladelpar trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free